Table 2. Chemical composition of MOLME analyzed by GC.
SL. |
Compounds |
Retention time (min) |
Area (%) |
|
1 |
Octasiloxane, 1,1,3,3,5,5,7,7,9,9,11,11,13,13,15,15-hexadecamethyl- |
5.04 |
0.32 |
|
2 |
Isobutyl ether |
5.98 |
1.96 |
|
3 |
2-Hexenal, (E)- |
6.25 |
0.33 |
|
4 |
Ethanol, 2-butoxy- |
6.39 |
0.51 |
|
5 |
Benzyl Alcohol |
8.36 |
0.65 |
|
6 |
D-Allose |
16.97 |
0.65 |
|
7 |
Hydroxylamine, O-decyl- |
18.47 |
0.42 |
|
8 |
1,2,3,5-Cyclohexanetetrol, (1.alpha.,2.beta.,3.alpha.,5.beta.)- |
18.79 |
1.68 |
|
9 |
Cycloheptasiloxane, tetradecamethyl- |
19.58 |
0.32 |
|
10 |
3-Buten-2-one, 4-(6,6-dimethyl-1-cyclohexen-1-yl)- |
20.69 |
0.33 |
|
11 |
9,10-Dimethyltricyclo[4.2.1.1(2,5)]decane-9,10-diol |
21.09 |
1.26 |
|
12 |
3,7,11,15-Tetramethyl-2-hexadecen-1-ol |
21.80 |
4.46 |
|
13 |
2-Pentadecanone, 6,10,14-trimethyl- |
21.92 |
1.02 |
|
14 |
Hexadecanoic acid, methyl ester |
23.39 |
9.99 |
|
15 |
9,12-Octadecadienoic acid, methyl ester |
27.82 |
1.41 |
|
16 |
Methyl (Z)-5,11,14,17-eicosatetraenoate |
28.03 |
7.23 |
|
17 |
Octadecanoic acid, methyl ester |
29.03 |
1.78 |
|
18 |
1,2-Benzenedicarboxylic acid, diisooctyl ester |
46.54 |
0.53 |
|
19 |
2,4-Imidazolidinedione,5-[3,4-bis[(trimethylsilyl)oxy]phenyl]-3-methyl-5-phenyl-1-(trimethylsilyl)- |
47.11 |
13.73 |
|
20 |
Spiro[9,9']difluorene, 2,2'-(2,5,8,11-tetraoxadodecane-1,12-diyl)- |
53.23 |
2.56 |
|
21 |
3,8,12-Tri-O-acetoxy-7-desoxyingol-7-one |
54.04 |
3.85 |
|
22 |
Cephalotaxine, 11-(acetyloxy)-, acetate (ester), (11.alpha.)- |
54.19 |
5.86 |
|
23 |
Norcodeine di-TMS derivative |
54.27 |
0.29 |
|
24 |
.psi.,.psi.-Carotene, 3,3',4,4'-tetradehydro-1,1',2,2'-tetrahydro-1-hydroxy-1'-methoxy- |
54.38 |
9.2 |
|
25 |
Acetamide, N-[5-(diethylamino)-2-[(2,4-dinitrophenyl)azo]-4-methoxyphenyl]- |
54.47 |
1.65 |
|
26 |
3,9-Epoxypregnan-14-ol-20-one, 3,11,18-triacetoxy- |
54.90 |
0.37 |
|
27 |
Isoxazole, 5-[3,3-dicyano-1-cyclohexylidene-2-morpholino-prop-2-enyl)]-3-p-methoxyphenyl- |
54.96 |
0.75 |
|
28 |
Gamma-Lumicolchicine |
55.14 |
0.16 |
|
29 |
Lycoxanthin |
55.21 |
0.77 |
|
30 |
4-(2-Methyl-1-cyclohexenyl)-trans-3-buten-2-one 2,4-dinitrophenylhydrazone |
55.32 |
1.25 |
|
31 |
10-(Methoxycarbonyl)-N-acetylcolchinol |
55.41 |
0.83 |
|
32 |
Butorphanol TMS derivative |
55.45 |
0.78 |
|
33 |
Canthaxanthin |
55.61 |
5.51 |
|
34 |
3,9.beta.;14,15-Diepoxypregn-16-en-20-one, 3,11.beta.,18-triacetoxy- |
55.78 |
2.28 |
|
35 |
9-Desoxo-9-x-acetoxy-3-desoxy-7.8.12-tri-O-acetylingol-3-one |
55.98 |
0.75 |
|
36 |
3,8,12-Tri-O-acetylingol 7-phenylacetate |
56.07 |
1.99 |
|
37 |
2-Butenoic acid, 2-methyl-, 2-(acetyloxy)-1,1a,2,3,4,6,7,10,11,11a-decahydro-7,10-dihydroxy-1,1,3,6,9-pentamethyl-4a,7a-epoxy-5H-cyclopenta[a]cyclopropa[f]cycloundecen-11-yl ester, [1aR-[1aR*,2R*,3S*,4aR*,6S*,7S*,7aS*,8E,10R*,11R*(E),11aS*]]- |
56.16 |
1.83 |
|
38 |
Alpha-Lumicolchicine |
56.40 |
0.65 |
|
39 |
9-Desoxo-9-xi-hydroxy-3,7,8,9,12-pentaacetate ingol |
56.83 |
0.61 |
|
40 |
Pregn-4-ene-3,11-dione, 17,20,21-tris[(trimethylsilyl)oxy]-, 3-(O-methyloxime), (20S)- |
56.93 |
2.16 |
|
41 |
6,6'-Diacetyl-7,7'-dihydroxy-2,2',4,4',5,5'-hexamethoxy-1,1'-binaphthalene |
57.01 |
1.65 |
|
42 |
Acetic acid, 1,1',4'-triacetoxy-5,5'-diisopropyl-6,7,6',7'-tetramethoxy-3,3'-dimethyl-[2,2']binaphthalenyl-4-yl ester |
57.81 |
1.10 |
|
43 |
3,9-Epoxypregn-16-en-14-ol-20-one, 11,18-diacetoxy-3-methoxy- |
57.91 |
0.82 |
|
44 |
Thymolphthalein |
58.56 |
0.42 |
|
45 |
Silane, [[(3.beta.,5.alpha.,11.beta.,20S)-pregnane-3,11,17,20,21-pentayl]pentakis(oxy)]pentakis[trimethyl- |
60.27 |
0.32 |
|
46 |
2,2-Bis[4-[(4,6-dichloro-1,3,5-triazin-2-yl)oxy]phenyl]-1,1,1,3,3,3-hexafluoropropane |
60.59 |
0.42 |
|
Total area=96.74 |